Who
In numbers
- Trades disclosed
- 14
- Buys
- 1
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 17 Feb 2023
- Last trade
- 16 Jun 2026
- Last filed
- 18 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jun 2026filed 18 Jun 2026 | GNLX GeneluxBiotechnology | SEC FORM 4 Code A | —28,409 at $0.00 | filing |
| 16 Jun 2026filed 18 Jun 2026 | GNLX Geneluxoption or derivative · Biotechnology | SEC FORM 4 Code A | —31,566 at $0.00 | filing |
| 16 Jun 2026filed 18 Jun 2026 | GNLX Geneluxoption or derivative · Biotechnology | SEC FORM 4 Code A | —31,566 at $0.00 | filing |
| 16 Jun 2026filed 18 Jun 2026 | GNLX GeneluxBiotechnology | SEC FORM 4 Code A | —28,409 at $0.00 | filing |
| 27 Aug 2025filed 29 Aug 2025 | GNLX Geneluxoption or derivative · Biotechnology | SEC FORM 4 Code A | —28,576 at $0.00 | filing |
| 27 Aug 2025filed 29 Aug 2025 | GNLX GeneluxBiotechnology | SEC FORM 4 Code A | —22,283 at $0.00 | filing |
| 1 Aug 2024filed 31 Dec 2024 | GNLX Geneluxoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,469 at $0.00 | filing |
| 1 Aug 2024filed 5 Aug 2024 | GNLX Geneluxoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,469 at $0.00 | filing |
| 1 Aug 2024filed 5 Aug 2024 | GNLX GeneluxBiotechnology | SEC FORM 4 Code A | —39,541 at $0.00 | filing |
| 29 May 2024filed 7 Jun 2024 | GNLX Geneluxoption or derivative · Biotechnology | SEC FORM 4 Code P | —8,000 | filing |
| 29 May 2024filed 7 Jun 2024 | GNLX GeneluxBiotechnology | SEC FORM 4 Bought | —8,000 | filing |
| 11 Sep 2023filed 13 Sep 2023 | GNLX Geneluxoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,397 at $0.00 | filing |
| 11 Sep 2023filed 13 Sep 2023 | GNLX GeneluxBiotechnology | SEC FORM 4 Code A | —3,460 at $0.00 | filing |
| 17 Feb 2023filed 2 May 2023 | GNLX GeneluxBiotechnology | SEC FORM 4 Code A | —1,000 at $0.00 | filing |
News
Head-To-Head Analysis: Foghorn Therapeutics (NASDAQ:FHTX) vs. Genelux (NASDAQ:GNLX)GNLX · themarketsdaily.com · 11 Oct 2026
0 headlines in the last 90 days name Mary Mirabelli; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.